High Rates of Hep C Seen for Patients Presenting to ED With Opioid Overdose

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 13, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 13, 2024 -- Patients presenting to emergency departments with opioid overdose have high rates of hepatitis C virus (HCV) infection, according to a study recently published in Cureus.

John A. Swift and Julie Stilley, Ph.D., from the University of Missouri School of Medicine in Columbia, conducted a retrospective cohort study to examine the prevalence of and testing history of HIV and HCV among opioid overdose patients from three emergency departments. One hundred thirty-four encounters for 120 patients were included in the study.

Forty-eight of the patients had a history of HCV testing and 54 had a history of HIV testing. The researchers found that 20 patients tested positive for HCV antibodies and one tested positive for HIV. Eight, six, and six patients had detectable HCV viral loads, undetectable HCV viral loads, and no quantitative testing, respectively. One patient had a detectable HIV viral load. Overall, 16.7 percent of both men and women had a history of a positive HCV test; compared with men, women were more likely to have ever received an HCV test (odds ratio, 2.68). Patients aged 55 to 64 years were more likely to test positive and were least likely to be untested compared with other age groups (odds ratios, 3.889 and 0.190, respectively).

"There may be potential benefits in the implementation of universal opt-out testing for HCV for patients being held for observation following an opioid overdose," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-14 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords